The present invention relates to isolithocholic acid (3β-hydroxy-5β-cholan-24-oic acid) and isoallolithocholic acid (3β-hydroxy-5α-cholan-24-oic acid) together with the respective 22-homo-analogs or the deuterated analogs, which are modified in 3-position, for preventing or treating Clostridioides difficile-associated disease in a mammalian subject.
本发明涉及孤立
胆烷酸(3β-羟基-5β-胆烷-24-酸)和异孤立
胆烷酸(3β-羟基-5α-胆烷-24-酸),以及相应的在3位修饰的22-同系物或
氘代同系物,用于预防或治疗哺乳动物主体中的难辨梭菌相关疾病。